LineaRX, an Applied DNA Sciences company, empowers the next generation of nucleic acid-based therapies through its LinearDNA^TM platform. The LinearDNA platform is an enzymatic cell-free DNA production system for the rapid large-scale manufacture of high-fidelity DNA.  DNA manufactured via the LinearDNA platform is free of adventitious DNA sequences and can be chemically modified to optimize DNA for specific applications, offering compelling advantages over plasmid DNA in many biotherapeutic applications including as an IVT template for mRNA production.